Newsweek’s Jonathan Alter, whose medical history makes the stem-cell debate a personal issue, has an excellent piece this week on why the ongoing political debate may be one of the most significant of the year.
My perspective could be skewed (all politics is local), but I have a gut feeling that President Bush is headed for a serious bruising on this issue, as are at least some of the 180 Republicans and 14 Democrats who voted last week against the stem-cell-research bill that passed the House. These members may look back ruefully on this vote as one that helped get them tossed out of office.
After all, every American who has a relative with one of these diseases — which means nearly every American — is beginning to understand the issue in a new way: it’s “pro-cure” versus “anti-cure,” with the anti-stem-cell folks in danger of being swept into the medical wastebin of history.
I think Alter’s absolutely right on this. The drive to undo Bush’s restrictive 2001 policy not only has the momentum, it has the support of the entire reality-based community. Some congressional Republicans were irritated when the Republican Main Street Partnership, a moderate group, conducted polls in GOP districts without alerting the relevant members, but the results of the survey were the most important detail — even Republicans in very conservative districts want to expand funding for stem-cell research and believe Bush’s policy is a mistake.
The margin of victory in the House, coupled by the soon-to-be bi-partisan success in the Senate, will create one of the starkest political controversies of Bush’s presidency. There have been plenty of partisan conflicts since the president took office, but this will be the first in which the White House is fighting a high-profile policy with broad bi-partisan support among lawmakers and the public.
The dynamic isn’t complicated. On one side will be the religious right and the movement’s inflexible and illogical demands. On the other side will be everyone else, including well-known anti-abortion lawmakers (such as Orrin Hatch and John McCain), Nancy Reagan, the entire scientific community, and every family in America with someone who has Parkinson’s, Alzheimer’s, a spinal cord injury, or one of the many other ailments that could be treated with stem-cell research — if only Bush would take his foot off the brake.
Will the United States be part of the most exciting medical research of our time? With global competitors poised to eat our lunch, a few private and state-funded efforts won’t be enough. “You can’t do research with your feet bound and one hand tied behind your back,” says Jerome Groopman, a professor at Harvard Medical School.
The lives of suffering people vs. the fate of a tiny clump of cells with fewer human properties than a mosquito. Bi-partisan majorities in Congress vs. a misguided White House. A portion of the far-right GOP base vs. the rest of the nation. “Pro-cure” vs “anti-cure.” The choice belongs to the president. I’m not optimistic.
Alter’s column said stem-cell research will probably “become one of the defining issues of the 2006 campaign.” It better be.